Tag: biotechnology

Company announcement No. 23 / 2026

The global high-end refractometer market is set to expand from USD 0.23 billion in 2025 to USD 0.38 billion by 2032, achieving a CAGR of 7.3%. Growth is propelled by rising demand for precise measurements in pharmaceuticals, biotechnology, and more. IoT-enabled sensors and advanced temperature compensation are boosting applications in continuous manufacturing. The online/retail segment will be the fastest-growing sales channel, driven by a shift to digital procurement and B2B marketplaces. The Asia Pacific region will register the highest CAGR due to rapid industrialization. Key players like Anton Paar GmbH and METTLER TOLEDO dominate this evolving market landscape.

SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced that senior management will participate in the following upcoming investor conferences.  

KNOXVILLE, Tenn., June 08, 2026 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that its 2026 annual stockholder meeting (the “Annual Meeting”), including shareholder meeting activities and a company update, will be accessible by Zoom webinar (the “Webinar”). The in-person meeting will be held on Thursday, June 18, 2026 at Perkins Place Office Building, located at 525 Portland Street, Knoxville, Tenn., beginning at 4:00 p.m. Eastern Time.

REYKJAVIK, Iceland, June 08, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for AVT16, a proposed interchangeable biosimilar to Entyvio^® (vedolizumab) lyophilized vial for intravenous administration.